Clinical trials data
Cue Reactivity Task in substance use and addiction trials: 158 registered studies
Every registered substance use and addiction study on ClinicalTrials.gov that names the Cue Reactivity Task in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
These counts cover cue reactivity tasks with any cues: drug, alcohol and smoking cues as well as food. The library's version, the Food Cue Reactivity Task, shows food.
- Registered substance use and addiction studies name it in an outcome measure
- 158
- Name it in a primary outcome, 56%
- 89 of 158
Tests named in the same studies
- 1
Stop-Signal Task16 studies, 8 as a primary outcome
- 2
Go/No-Go Task10 studies, 4 as a primary outcome
- 3
Dot-Probe Task9 studies, 3 as a primary outcome
- 4
Implicit Association Test (IAT)4 studies, 4 as a primary outcome
- 5
N-Back Task4 studies, 2 as a primary outcome
- 6
Iowa Gambling Lite4 studies, 1 as a primary outcome
- 7
Dimensional Change Card Sort3 studies, 1 as a primary outcome
- 8
Mirror Tracing Task3 studies, 1 as a primary outcome
- 9
Balloon Risk2 studies, 1 as a primary outcome
- 10
Continuous Performance Test2 studies, 1 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 3 | 3 |
| 2010 | 2 | 1 |
| 2011 | 7 | 4 |
| 2012 | 2 | 1 |
| 2013 | 3 | 2 |
| 2014 | 4 | 1 |
| 2015 | 4 | 3 |
| 2016 | 7 | 2 |
| 2017 | 8 | 4 |
| 2018 | 8 | 2 |
| 2019 | 14 | 11 |
| 2020 | 14 | 11 |
| 2021 | 13 | 8 |
| 2022 | 8 | 4 |
| 2023 | 21 | 5 |
| 2024 | 9 | 5 |
| 2025 | 11 | 7 |
| 2026 | 16 | 12 |
Phases and study sizes
By phase
- Early phase 12 studies, 1 as a primary outcome
- Phase 17 studies, 6 as a primary outcome
- Phase 1/28 studies, 5 as a primary outcome
- Phase 250 studies, 24 as a primary outcome
- Phase 2/33 studies, 1 as a primary outcome
- Phase 31 studies, 1 as a primary outcome
- Phase 44 studies, 4 as a primary outcome
- Not applicable76 studies, 42 as a primary outcome
- Observational7 studies, 5 as a primary outcome
Participants per study
- Phase 250 median, 31 to 76
- Not applicable83 median, 40 to 123
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 47 | 50 | 31 to 76 |
| Not applicable | 76 | 83 | 40 to 123 |
When substance use and addiction trials measure it
Latest time point of each outcome
- Within a day29 outcomes, 22 as a primary outcome
- Up to 4 weeks57 outcomes, 30 as a primary outcome
- 1 to 3 months34 outcomes, 17 as a primary outcome
- 3 to 6 months10 outcomes, 3 as a primary outcome
- 6 to 12 months1 outcomes, 0 as a primary outcome
- 1 to 2 years1 outcomes, 1 as a primary outcome
- No duration given25 outcomes, 16 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
132 of the 157 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting36 studies, 21 as a primary outcome
- Not yet recruiting12 studies, 9 as a primary outcome
- Active, not recruiting5 studies, 2 as a primary outcome
- Completed86 studies, 47 as a primary outcome
- Stopped early9 studies, 5 as a primary outcome
- Status unknown10 studies, 5 as a primary outcome
What they test
- Behavioral50 studies, 29 as a primary outcome
- Drug72 studies, 40 as a primary outcome
- Device33 studies, 17 as a primary outcome
- Dietary supplement1 studies, 0 as a primary outcome
- Procedure3 studies, 2 as a primary outcome
- Biological1 studies, 1 as a primary outcome
- Radiation1 studies, 1 as a primary outcome
- Combination product1 studies, 0 as a primary outcome
- Other30 studies, 19 as a primary outcome
- None given2 studies, 1 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States107 studies, 66 as a primary outcome
- Germany14 studies, 10 as a primary outcome
- China7 studies, 5 as a primary outcome
- Denmark4 studies, 0 as a primary outcome
- Belgium3 studies, 0 as a primary outcome
- Switzerland3 studies, 0 as a primary outcome
- Canada2 studies, 0 as a primary outcome
- France2 studies, 1 as a primary outcome
- Israel2 studies, 0 as a primary outcome
- Portugal2 studies, 1 as a primary outcome
- Australia1 studies, 0 as a primary outcome
- Brazil1 studies, 0 as a primary outcome
15 countries in all. A study with sites in several counts in each; 7 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed substance use and addiction studies that name the Cue Reactivity Task: 49 of 86, 57%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed substance use and addiction studies that name the Cue Reactivity Task | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 14, 16% | 776, 10% |
| Results on ClinicalTrials.gov only | 22, 26% | 1,139, 14% |
| A results paper only | 13, 15% | 1,711, 22% |
| Neither | 37, 43% | 4,327, 54% |
The 158 studies
158 studies match. 89 name the Cue Reactivity Task in a primary outcome. Median size 60 participants. Median time to the primary outcome: 2 weeks.
Loading 158 studies; the filters turn on when they arrive.
2026 is partly planned starts. Not shown: 3 planned to start after 2026.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 3 | 3 |
| 2010 | 2 | 1 |
| 2011 | 7 | 4 |
| 2012 | 2 | 1 |
| 2013 | 3 | 2 |
| 2014 | 4 | 1 |
| 2015 | 4 | 3 |
| 2016 | 7 | 2 |
| 2017 | 8 | 4 |
| 2018 | 8 | 2 |
| 2019 | 14 | 11 |
| 2020 | 14 | 11 |
| 2021 | 13 | 8 |
| 2022 | 8 | 4 |
| 2023 | 21 | 5 |
| 2024 | 9 | 5 |
| 2025 | 11 | 7 |
| 2026 | 16 | 12 |
Library tests named most
Conditions
Phases
Participants
Lead sponsor: industry 4, NIH 7, other 147. Interventional 151, observational 7.
As a primary outcomeSecondary or other outcomeThe Cue Reactivity Task
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07879612 | Start2027 | PhasePhase 2 | ConditionsSubstance use and addiction | Participants40 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07878624 | Start2025 | PhaseObservational | ConditionsSubstance use and addiction | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07829510 | Start2026 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Substance use and addiction, Anxiety, PTSD and OCD | Participants300 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07814755 | Start2026 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants50 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07775807 | Start2026 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants5 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07770555 | Start2027 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants12 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07735923 | Start2026 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants104 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07698470 | Start2026 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants45 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07523633 | Start2026 | PhasePhase 2 | ConditionsSubstance use and addiction | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07452146 | Start2026 | PhasePhase 2 | ConditionsSubstance use and addiction | Participants64 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07397507 | Start2026 | PhaseNot applicable | ConditionsSubstance use and addiction, Anxiety, PTSD and OCD | Participants108 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07387796 | Start2026 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07296094 | Start2026 | PhasePhase 2 | ConditionsSubstance use and addiction | Participants36 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07292519 | Start2026 | PhasePhase 2 | ConditionsObesity and diabetes, Substance use and addiction | Participants46 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07265752 | Start2027 | PhasePhase 2 | ConditionsSubstance use and addiction | Participants6 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07220148 | Start2026 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants234 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07154160 | Start2026 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants21 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07145866 | Start2026 | PhasePhase 4 | ConditionsSubstance use and addiction | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07118618 | Start2026 | PhasePhase 2 | ConditionsSubstance use and addiction | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07094061 | Start2025 | PhaseNot applicable | ConditionsHealthy volunteers, Substance use and addiction | Participants294 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07091877 | Start2024 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants252 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07086014 | Start2024 | PhaseObservational | ConditionsSubstance use and addiction | Participants88 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06943859 | Start2026 | PhasePhase 2 | ConditionsSubstance use and addiction | Participants50 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06939088 | Start2025 | PhasePhase 2 | ConditionsSchizophrenia and psychosis, Substance use and addiction | Participants108 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06870110 | Start2025 | PhaseNot applicable | ConditionsSubstance use and addiction | Participants40 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
Questions, answered from the data
How many substance use and addiction trials use the Cue Reactivity Task?
158 registered substance use and addiction studies on ClinicalTrials.gov name it in an outcome measure, 89 of them in a primary outcome: 18% of the condition's 895 studies with a cognitive outcome, against 1% of all of them. It is the test substance use and addiction trials name most.
Which tests do substance use and addiction trials use with the Cue Reactivity Task?
The Stop-Signal Task (16 studies), the Go/No-Go Task (10 studies) and the Dot-Probe Task (9 studies).
How many participants do phase 2 substance use and addiction trials that use the Cue Reactivity Task enroll?
Half of the phase 2 studies that name it enroll 50 participants or fewer, and the middle half enroll 31 to 76. 47 of them give a size.
When do substance use and addiction trials measure the Cue Reactivity Task?
Half of the primary outcomes that name the Cue Reactivity Task are measured within 2 weeks of the start, and the middle half from the first day to 5 weeks. 73 primary outcomes give a duration.
How many completed substance use and addiction trials that use the Cue Reactivity Task have reported results?
49 of the 86 completed studies that name it, 57%, have reported results: 36 posted them on ClinicalTrials.gov, 27 have a results paper linked to the registry record, and 14 did both. The other 37 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run the Cue Reactivity Task in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.